In office sampling of eosinophil peroxidase to diagnose eosinophilic chronic rhinosinusitis
International Forum of Allergy & Rhinology · 2025
DOI: 10.1002/alr.23448 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Forum of Allergy & Rhinology, 2025. Verfasst von Jacquelyn K Callander und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, University of California, San Francisco, California, USA. Hauptthemen laut MEDLINE: Sinusitis, Rhinitis, Eosinophil Peroxidase, Biomarkers. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
Background
Practical biomarkers for endotypic characterization of chronic rhinosinusitis (CRS) remain elusive, hindering clinical utility. Eosinophil peroxidase (EPX) is an enzyme released by activated eosinophils. The objective of this study was to evaluate a clinic EPX assay as a marker of eosinophilic CRS.
Methods
Subjects with and without CRS presenting to a tertiary care rhinology clinic were prospectively enrolled, and nasal cytology brushings were collected from the middle meatus during in‐clinic nasal endoscopy. ELISA assay was used to quantify EPX levels, and a customized multiplex immunoassay was used to quantify inflammatory cytokine mediators. Findings were correlated with clinical data.
Results
Forty‐two subjects were enrolled, including 31 CRS subjects and 11 controls. Median EPX levels were 125.0 ng/mL (standard deviation [SD] 1745.8) and 6.5 ng/mL (SD 99.0) for CRS group and controls, respectively ( p = 0.003). EPX levels were associated with history of asthma ( p = 0.015), allergies ( p = 0.028), polyps ( p = 0.0006), smell loss ( p = 0.006), and systemic eosinophilia or elevated immunoglobulin E ( p ≤ 0.0001). Twenty‐eight subjects from both the CRS and control groups had prior pathology for comparison, with histologic confirmation of local tissue eosinophilia (>10 eosinophils/hpf) in 11 subjects. This subgroup had a median EPX level of 967.5 ng/mL compared to 10.6 ng/mL in 17 subjects without local tissue eosinophilia ( p = 0.0008). EPX levels were positively correlated to interleukin‐5 levels ( p = 0.0005).
Conclusion
EPX levels can be measured via well‐tolerated in‐clinic collection of nasal mucus. EPX levels are associated with clinical markers of type 2 inflammation and tissue eosinophilia and may provide a valuable diagnostic tool to delineate eosinophilic CRS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, University of California, San Francisco, California, USA.
- Cardiovascular Research Institute, University of California, San Francisco, California, USA.
- Division of Pulmonary, Critical Care, Allergy and Sleep, Department of Medicine, University of California, San Francisco, California, USA.
ORCID-Profile: Jacquelyn K Callander, Steven D Pletcher, Jose G Gurrola
Förderung
- NHLBI NIH HHS
Zitieren
APA
Callander, J. K., Charbit, A. R., Khanna, K., Fahy, J. V., Tang, M., Liegeois, M., Pletcher, S. D., Goldberg, A. N., Gurrola, J. G., Murr, A. H., Butrymowicz, A., & Loftus, P. A. (2025). In office sampling of eosinophil peroxidase to diagnose eosinophilic chronic rhinosinusitis. International Forum of Allergy & Rhinology. https://doi.org/10.1002/alr.23448
Vancouver
Callander JK, Charbit AR, Khanna K, Fahy JV, Tang M, Liegeois M, et al. In office sampling of eosinophil peroxidase to diagnose eosinophilic chronic rhinosinusitis. International Forum of Allergy & Rhinology. 2025. doi:10.1002/alr.23448
BibTeX
@article{Callander2025,
author = {Callander, Jacquelyn K and Charbit, Annabelle R and Khanna, Kritika and Fahy, John V and Tang, Monica and Liegeois, Maude and Pletcher, Steven D and Goldberg, Andrew N and Gurrola, Jose G and Murr, Andrew H and Butrymowicz, Anna and Loftus, Patricia A},
title = {In office sampling of eosinophil peroxidase to diagnose eosinophilic chronic rhinosinusitis},
journal = {International Forum of Allergy & Rhinology},
year = {2025},
doi = {10.1002/alr.23448}
}
EUVIMED